Aptamer Sciences Stock Price To Sales
291650 Stock | KRW 1,816 73.00 3.86% |
Aptamer Sciences fundamentals help investors to digest information that contributes to Aptamer Sciences' financial success or failures. It also enables traders to predict the movement of Aptamer Stock. The fundamental analysis module provides a way to measure Aptamer Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptamer Sciences stock.
Aptamer |
Aptamer Sciences Company Price To Sales Analysis
Aptamer Sciences' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Based on the latest financial disclosure, Aptamer Sciences has a Price To Sales of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Price To Sales (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Aptamer Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptamer Sciences' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptamer Sciences could also be used in its relative valuation, which is a method of valuing Aptamer Sciences by comparing valuation metrics of similar companies.Aptamer Sciences is currently under evaluation in price to sales category among its peers.
Aptamer Fundamentals
Return On Equity | -19.57 | |||
Return On Asset | -0.11 | |||
Operating Margin | (14.32) % | |||
Current Valuation | 169.03 B | |||
Shares Owned By Insiders | 33.00 % | |||
Shares Owned By Institutions | 0.30 % | |||
Revenue | 269.28 M | |||
Gross Profit | 157.44 M | |||
EBITDA | (3.49 B) | |||
Net Income | (3.83 B) | |||
Cash And Equivalents | 1.01 B | |||
Total Debt | 68.63 M | |||
Cash Flow From Operations | (3.47 B) | |||
Market Capitalization | 74.03 B | |||
Total Asset | 33.26 B | |||
Net Asset | 33.26 B |
About Aptamer Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptamer Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptamer Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptamer Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptamer Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptamer Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptamer Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptamer Stock
The ability to find closely correlated positions to Aptamer Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptamer Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptamer Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptamer Sciences to buy it.
The correlation of Aptamer Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptamer Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptamer Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptamer Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Aptamer Stock
Aptamer Sciences financial ratios help investors to determine whether Aptamer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptamer with respect to the benefits of owning Aptamer Sciences security.